In a separate study, it was assessed as a component of a short peptide delivery system based on particle formation.42 The CPQ system can be used for screening to identify neoepitopes in other murine cell lines and in the future in human cancer cell lines using humanized mice that express transgenic human leukocyte antigen and engrafted with human CD8+ T cells. This evidence concerns the gene CD8A and cancer.